Post by mango on Jul 8, 2017 20:26:59 GMT -5
If there is a potential deal with the UAE, why is there so little traffic originating from the UAE on the afrezza.com website?
??so MNholdem, please explain why almost no traffic originates from the UAE over the last 30 and 90 days, but you so strongly believe that MNKD is going to announce a shipment there?
Reasons why I believe it is not likely at all:
To be listed as a top 11 country .45% of total traffic is the minimum amount. That would be 162 total visits or 44 unique monthly visitors both very low thresholds to make the list for a country preparing for a new drug.
I signed up for a free trial and went back 3 months and still no UAE in the top 20 and the threshold would be about 130 visits over the last three months or .26% of total visits during the last 90 days.
Only two countries are listed for investors.mannkind.com, USA and Ukraine. Ukraine is probably where the web developers reside for the third party investor website.
pro.similarweb.com/?newSocialUser=true#/website/worldwide-overview/afrezza.com/*/999/1m?webSource=Total
A: Last week we announced a partnership with Brazil. We are also looking at the Middle East — such as United Arab Emirates — as a key part of the world that, for cultural reasons, would really prefer an inhalable insulin over an injectable.
India and China are two fantastic markets. There’s just a pandemic going on out there in the marketplace. India has 80 million people living with diabetes. This, unfortunately, is a 30- to 40-year disease. The developing countries are really setting themselves up for a significant cost burden in taking care of people in the future. Today, they are not seeing a lot of damage, but over the next 10 years they will see a lot of damage from not managing their sugars.
When you see 80 million people in a country really heading for disaster, that’s going to have a significant consequence for society.
India and China are two fantastic markets. There’s just a pandemic going on out there in the marketplace. India has 80 million people living with diabetes. This, unfortunately, is a 30- to 40-year disease. The developing countries are really setting themselves up for a significant cost burden in taking care of people in the future. Today, they are not seeing a lot of damage, but over the next 10 years they will see a lot of damage from not managing their sugars.
When you see 80 million people in a country really heading for disaster, that’s going to have a significant consequence for society.
* Michael Castagna, CEO of MannKind Corporation—June 11, 2017
m.newstimes.com/business/article/New-MannKind-CEO-Afrezza-global-markets-are-key-11208232.php#photo-13056480
